Mark J. Foley, CEO: Revance Therapeutics RVNC Sell · Filed 23/05/16

Trade details

Type: Insider sale
Amount: $2,433,943.85
Shares · price: 70,447 sh · $34.55 a share
Held after: 923,212 sh
Stock: Revance Therapeutics RVNC
Person: Mark J. FoleyCEO
Trade date: 23/05/15
Filed: 23/05/16
Days to filing: 1 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/15~23/06/14

Mark J. Foley's recent trades

Mark J. FoleyDirector
SellGlaukos
Sell
Glaukos
GKOS
$2.5M
20,687 sh
$2.5M
Filed 25/02/28
Traded 25/02/26
Mark J. FoleyDirector
Planned saleGlaukos
Planned sale
Glaukos
GKOS
$2.5M
20,687 sh
$2.5M
Filed 25/02/26
Traded 25/02/26
Mark J. FoleyCEO
BuyRevance Therapeutics
Buy
Revance Therapeutics
RVNC
$209.4K
30,000 sh
$209.4K
Filed 24/03/08
Traded 24/03/06
Mark J. FoleyDirector
SellGlaukos
Sell
Glaukos
GKOS
$423.5K
4,560 sh
$423.5K
Filed 24/02/26
Traded 24/02/23
Mark J. FoleyCEO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$593.1K
26,279 sh
$593.1K
Filed 23/08/04
Traded 23/08/03